Sergio H.
- Country
- Spain
- Department
- Oncolgy
Research Overview
Data & Insights
Has run more than one trial at 0 of 132 partner sites.
Specializations
Breast Cancer Specialization
The investigator focuses on advanced therapeutic approaches for breast cancer, with particular emphasis on HER2-positive and hormone receptor-positive disease.
- High-risk breast cancer management
- Post-neoadjuvant therapy strategies
- Node-positive breast cancer treatment
Expertise extends to novel therapeutic approaches for both early-stage and advanced breast cancer cases.
Targeted Therapies
Specializes in evaluating innovative targeted treatments including antibody-drug conjugates such as Trastuzumab Deruxtecan and endocrine therapy approaches.
- HER2-targeted therapeutics
- Endocrine resistance management
- Novel therapeutic agents
Focus on personalized treatment strategies based on specific breast cancer subtypes.
Treatment Outcomes
Investigates disease-free survival and treatment efficacy in high-risk breast cancer populations, with emphasis on recurrence prevention.
- Invasive disease-free survival assessment
- Risk stratification approaches
- Long-term outcome evaluation
Dedicated to improving survival outcomes through targeted therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.